(IPGP) IPG Photonics - Overview
Sector: Technology | Industry: Semiconductor Equipment & Materials | Exchange: NASDAQ (USA) | Market Cap: 5.051m USD | Total Return: 77.7% in 12m
Avg Turnover: 58.4M
Qual. Beats: 0
Rev. Trend: -85.6%
Qual. Beats: 4
Warnings
P/E ratio 175.0
Choppy
Tailwinds
No distinct edge detected
IPG Photonics Corporation (IPGP) specializes in the development and production of high-performance fiber lasers, amplifiers, and integrated laser systems. The company operates a vertically integrated business model, manufacturing its own semiconductor diodes and optical fibers to maintain control over supply chains and component performance. Its product portfolio includes pulsed and continuous wave lasers used across diverse sectors such as automotive manufacturing, medical device production, and aerospace engineering.
The industrial laser sector is currently shifting toward fiber technology due to its superior energy efficiency and lower maintenance requirements compared to traditional CO2 lasers. IPG Photonics serves this demand through direct sales and global distributors, providing both standalone laser sources and complete robotic welding or cutting systems. For deeper insights into these industry trends, consider reviewing the comprehensive data available on ValueRay.
Headquartered in Marlborough, Massachusetts, the firm supports a wide range of applications from micro-electronics drilling to heavy-duty shipbuilding. By offering complementary components like optical delivery cables and process monitoring sensors, the company positions itself as a full-suite provider for laser-based materials processing.
- China manufacturing slowdown reduces demand for high-power industrial fiber lasers
- EV battery production investments drive revenue growth in welding applications
- Emerging handheld laser welding market creates new consumer and professional segments
- Vertical integration of diode production maintains industry-leading gross profit margins
- Geopolitical tensions impact sales growth within the critical Chinese industrial market
| Net Income: 28.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -5.38 > 1.0 |
| NWC/Revenue: 113.9% < 20% (prev 130.8%; Δ -16.92% < -1%) |
| CFO/TA 0.02 > 3% & CFO 56.4m > Net Income 28.9m |
| Net Debt (-796.6m) to EBITDA (70.9m): -11.23 < 3 |
| Current Ratio: 5.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.9m) vs 12m ago 0.19% < -2% |
| Gross Margin: 37.56% > 18% (prev 0.35%; Δ 3.72k% > 0.5%) |
| Asset Turnover: 43.95% > 50% (prev 41.12%; Δ 2.83% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: 0.49 (Total Current Assets 1.43b - Total Current Liabilities 247.2m) / Total Assets 2.42b |
| B: 1.09 (Retained Earnings 2.65b / Total Assets 2.42b) |
| C: 0.00 (EBIT TTM 3.54m / Avg Total Assets 2.37b) |
| D: 8.49 (Book Value of Equity 2.60b / Total Liabilities 305.8m) |
| Altman-Z'' = 15.70 = AAA |
| DSRI: 1.02 (Receivables 198.1m/176.9m, Revenue 1.04b/952.9m) |
| GMI: 0.92 (GM 37.56% / 34.68%) |
| AQI: 1.25 (AQ_t 0.15 / AQ_t-1 0.12) |
| SGI: 1.09 (Revenue 1.04b / 952.9m) |
| TATA: -0.01 (NI 28.9m - CFO 56.4m) / TA 2.42b) |
| Beneish M = -2.87 (Cap -4..+1) = A |
As of May 25, 2026, the stock is trading at USD 119.00 with a total of 492,763 shares traded.
Over the past week, the price has changed by +15.80%,
over one month by -4.46%,
over three months by -9.64% and
over the past year by +77.72%.
IPG Photonics has received a consensus analysts rating of 3.11. Therefore, it is recommended to hold IPGP.
- StrongBuy: 2
- Buy: 0
- Hold: 5
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 135.8 | 14.1% |
P/E Trailing = 175.0
P/E Forward = 79.3651
P/S = 4.8496
P/B = 2.3872
P/EG = 1.83
Revenue TTM = 1.04b USD
EBIT TTM = 3.54m USD
EBITDA TTM = 70.9m USD
Long Term Debt = 11.3m USD (estimated: total debt 16.3m - short term 5.00m)
Short Term Debt = 5.00m USD (from shortTermDebt, last quarter)
Debt = 16.3m USD (from shortLongTermDebtTotal, last quarter) (leases 16.3m already included)
Net Debt = -796.6m USD (calculated: Debt 16.3m - CCE 812.9m)
Enterprise Value = 4.25b USD (5.05b + Debt 16.3m - CCE 812.9m)
Interest Coverage Ratio = unknown (Ebit TTM 3.54m / Interest Expense TTM 0.0)
EV/FCF = -307.1x (Enterprise Value 4.25b / FCF TTM -13.9m)
FCF Yield = -0.33% (FCF TTM -13.9m / Enterprise Value 4.25b)
FCF Margin = -1.33% (FCF TTM -13.9m / Revenue TTM 1.04b)
Net Margin = 2.78% (Net Income TTM 28.9m / Revenue TTM 1.04b)
Gross Margin = 37.56% ((Revenue TTM 1.04b - Cost of Revenue TTM 650.3m) / Revenue TTM)
Gross Margin QoQ = 37.48% (prev 36.10%)
Tobins Q-Ratio = 1.76 (Enterprise Value 4.25b / Total Assets 2.42b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 16.3m)
Taxrate = 31.04% (14.0m / 45.1m)
NOPAT = 2.44m (EBIT 3.54m * (1 - 31.04%))
Current Ratio = 5.80 (Total Current Assets 1.43b / Total Current Liabilities 247.2m)
Debt / Equity = 0.01 (Debt 16.3m / totalStockholderEquity, last quarter 2.12b)
Debt / EBITDA = -11.23 (Net Debt -796.6m / EBITDA 70.9m)
Debt / FCF = 57.49 (negative FCF - burning cash) (Net Debt -796.6m / FCF TTM -13.9m)
Total Stockholder Equity = 2.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.22% (Net Income 28.9m / Total Assets 2.42b)
RoE = 1.37% (Net Income TTM 28.9m / Total Stockholder Equity 2.11b)
RoCE = 0.17% (EBIT 3.54m / Capital Employed (Equity 2.11b + L.T.Debt 11.3m))
RoIC = 0.12% (NOPAT 2.44m / Invested Capital 2.10b)
WACC = 11.73% (E(5.05b)/V(5.07b) * Re(11.77%) + D(16.3m)/V(5.07b) * Rd(0.0%) * (1-Tc(0.31)))
Discount Rate = 11.77% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.44 | Cagr: -3.65%
[DCF] Fair Price = unknown (Cash Flow -13.9m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.02 | # QB: 0
Revenue Correlation: -85.64 | Revenue CAGR: -12.07% | SUE: 0.87 | # QB: 4
EPS current Quarter (2026-06-30): EPS=0.39 | Chg30d=-9.01% | Revisions=-50% | Analysts=7
EPS next Quarter (2026-09-30): EPS=0.43 | Chg30d=-9.00% | Revisions=-50% | Analysts=7
EPS current Year (2026-12-31): EPS=1.62 | Chg30d=-8.78% | Revisions=-50% | GrowthEPS=+14.0% | GrowthRev=+10.7%
EPS next Year (2027-12-31): EPS=2.31 | Chg30d=-10.41% | Revisions=-43% | GrowthEPS=+42.8% | GrowthRev=+9.0%
[Analyst] Revisions Ratio: -50%